Sun Pharmaceutical Industries

Sustainability Report and Carbon Intensity Rankings

Is Sun Pharmaceutical Industries doing their part?

Their DitchCarbon score is 46

Sun Pharmaceutical Industries has a DitchCarbon Score of 46 out of 100, indicating a moderate level of sustainability in their operations. This score reflects the company’s carbon intensity, suggesting there is significant room for improvement in reducing emissions. A higher score would denote stronger efforts towards minimizing carbon intensity and enhancing sustainability.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Sun Pharmaceutical Industries operates within the industrial manufacturing sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Medium

High

Very high

Sun Pharmaceutical Industries, located in India, operates in a region with a very high carbon intensity rating. This suggests that the company’s sustainability efforts may be challenged by the high carbon footprint associated with the local energy grid and industrial practices.
4.71%

...this company is doing 4.71% better in emissions than the industry average.

Founded in 1983 and headquartered in Mumbai, Sun Pharmaceutical Industries operates within the industrial manufacturing sector, specifically in the pharmaceutical industry. As the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical firm, Sun Pharma offers a wide range of high-quality, affordable medicines. With a robust global presence, the company boasts 50 manufacturing facilities worldwide, a diverse workforce, and a strong commitment to innovation through substantial R&D investments.

emission intelligence's platform recommendations for Sun Pharmaceutical Industries

Sun Pharmaceutical Industries could significantly reduce their scope 2 emissions by setting clear and achievable targets for reducing consumption across all purchased energy types, including electricity, heat, steam, and cooling.

Good news, Sun Pharmaceutical has set SBTi climate commitments

Sun Pharmaceutical Industries has committed to setting targets for reducing greenhouse gas emissions from their operations, aligning with the goal of limiting global warming to 1.5°C. This involves significant cuts in their direct and indirect emissions to contribute to climate change mitigation efforts.
Participating

The Ultimate Guide to Building Sustainability Into Procurement​

In this guide you can learn about the three stages of sustainable procurement.

Stage 1) – Identify and Communicate
Sustainability Maturity

Stage 2) – Start to Give Preference to Mature Suppliers

Stage 3) – Make Climate Action a “Hard” Measure for Procurement

The Ultimate Guide to Building Sustainability Into Procurement​​

In this guide you can learn about the three stages of sustainable procurement.

Stage 1) – Identify and Communicate
Sustainability Maturity

Stage 2) – Start to Give Preference to Mature Suppliers

Stage 3) – Make Climate Action a “Hard” Measure for Procurement

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Looking for a specific company?

Search our company directory or contact us for custom data requests.